• Cognex Vertrieb: +49-721-958-8052

  • Kontakt

News

FOR IMMEDIATE RELEASE

NATICK, MA September 10, 2007

Cognex Corporation Appoints New Independent Registered Public Accounting Firm

NATICK, MA, September 10, 2007 — Cognex Corporation (NASDAQ: CGNX) today announced that the Audit Committee of the company’s Board of Directors has appointed Grant Thornton LLP as the company’s independent registered public accounting firm, effective September 7, 2007. Grant Thornton LLP replaces Ernst & Young LLP, which has served as the company’s firm of record since the fiscal year ended December 31, 2003. The decision to change independent registered public accounting firms was unanimously approved by the Audit Committee and is not the result of any disagreement with Ernst & Young on any matter of accounting principles or practice, financial statement disclosure, or auditing scope or auditing procedure

Forward-Looking Statement

Certain statements made in this press release, which do not relate solely to historical matters, are forward-looking statements. You can identify these forward-looking statements by use of the words “expects,” “anticipates,” ”estimates,” “believes,” “projects,” “intends,” “plans,” “will,” “may,” “should,” “shall” and similar words. These forward-looking statements, which include statements regarding business trends, revenue growth and the company’s financial outlook, involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include: (1) global economic conditions that impact the capital spending trends of manufacturers in a variety of industries; (2) the cyclicality of the semiconductor and electronics industries; (3) the reliance upon certain sole-source suppliers to manufacture and deliver critical components for the company’s products; (4) the inability to design and manufacture high-quality products; (5) the technological obsolescence of current products and the inability to develop new products; (6) the inability to protect the company’s proprietary technology and intellectual property; (7) the challenges in integrating acquisitions and achieving anticipated benefits; (8) the failure to effectively manage product transitions or accurately forecast customer demand; (9) the inability to attract and retain skilled employees; and (10) the other risks detailed in the company’s reports filed with the SEC, including the company’s Form 10-K for the fiscal year ended December 31, 2006. You should not place undue reliance upon any such forward-looking statements, which speak only as of the date made. The company disclaims any obligation to update forward-looking statements after the date of such statements.

 

CONTACT:
Susan Conway
Director of Investor Relations
Telephone: (508) 650-3353
Email: susan.conway@cognex.com

Über Cognex Corporation

Cognex Corporation entwirft, entwickelt, fertigt und vermarktet unterschiedlichste bildbasierte Produkte, die alle mit Techniken der künstlichen Intelligenz (KI) ausgestattet sind und so über menschenähnliche Fähigkeiten verfügen, so dass sie Entscheidungen anhand dessen treffen können, was sie sehen. Zu den Produkten von Cognex gehören industrielle Bildverarbeitungssysteme, -sensoren und Barcode-Lesegeräte, die weltweit in Betrieben und Verteilzentren verwendet werden, wo sie Herstellungs- und Versandfehler verhindern.

Cognex ist der weltweit führende Anbieter von industriellen Bildverarbeitungssystemen mit bereits über 2 Millionen ausgelieferten bildbasierten Geräten, die einem kumulierten Umsatz von über 7 Mrd. USD seit Gründung des Unternehmens im Jahre 1981 entsprechen. Neben dem Sitz in Natick (Massachusetts, USA) verfügt Cognex in Nord- und Südamerika, Europa und Asien über regionale Zweigstellen und Vertragshändler. Für nähere Infos besuchen Sie Cognex online auf www.cognex.com.

ERHALTEN SIE ZUGANG ZU SUPPORT & TRAINING FÜR PRODUKTE & MEHR

Werden Sie Teil von MyCognex

SIE HABEN EINE FRAGE?

Cognex is weltweit vertreten, um Sie bei Ihren Vision- und Barcode-Anwendungen zu unterstützen.

Kontakt
Loading...